Sector consensus Monte Rosa Therapeutics, Inc.
Stocks
GLUE
US61225M1027
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.45 USD | +6.69% |
|
-3.89% | +49.55% |
| 30/06 | Monte Rosa Therapeutics, Inc.(NasdaqGS:GLUE) added to Russell 2500 Growth Benchmark | CI |
| 29/06 | Monte Rosa Therapeutics, Inc.(NasdaqGS:GLUE) dropped from Russell Microcap Value Benchmark Index | CI |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 33.17 | +50.89% | 6 | ||||||
| 669.22 | +13.7% | 23 | ||||||
| 200.27 | +8.87% | 22 | ||||||
| 229.63 | +10.64% | 19 | ||||||
| 415.05 | +36.55% | 27 | ||||||
| 2,56,664.68 | +46.58% | 24 | ||||||
| 261.87 | +12.57% | 18 | ||||||
| 456 | -13.99% | 12 | ||||||
| 71.03 | +2.2% | 14 | ||||||
| 180.81 | +8.86% | 16 | ||||||
| 138.56 | +15.37% | 6 | ||||||
| 228.4 | -0.59% | 15 | ||||||
| 70 | -1.91% | 12 | ||||||
| 66.06 | +18.12% | 16 | ||||||
| 130.53 | -2.46% | 12 | ||||||
| 124.19 | +12.49% | 21 | ||||||
| 93.23 | +64.28% | 22 | ||||||
| 610.05 | +93.94% | 19 | ||||||
| 51.59 | -0.54% | 17 | ||||||
| 44.46 | +7.29% | 14 | ||||||
| Average | 13,036.94 | +19.14% | 17 | ||||||
| Weighted average by Cap. | 20,358.52 | +17.57% | 19 |
- Stock Market
- Stocks
- GLUE Stock
- Sector Monte Rosa Therapeutics, Inc.
- Sector consensus
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
